Pnc Financial Services Group, Inc. Pliant Therapeutics, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $190 Billion
- Q1 2025
A detailed history of Pnc Financial Services Group, Inc. transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 2,640 shares of PLRX stock, worth $3,537. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,640
Previous 230
1047.83%
Holding current value
$3,537
Previous $3,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding PLRX
# of Institutions
154Shares Held
62.2MCall Options Held
279KPut Options Held
7.1K-
Tang Capital Management LLC San Diego, CA6MShares$8.04 Million0.53% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.4MShares$7.24 Million0.25% of portfolio
-
Black Rock Inc. New York, NY4.97MShares$6.66 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.33MShares$4.47 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.05MShares$4.09 Million0.0% of portfolio
About PLIANT THERAPEUTICS, INC.
- Ticker PLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,682,000
- Market Cap $65.2M
- Description
- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...